“…The blood saving protocol used in this study, however, has proved to be useful because the proportion patients receiving transfusions (2.9% for Group A, 5.2% for Group B) was greatly reduced with respect to that of previously published series 2‐4,7,8,17,18 despite 21 percent (66/312) of the patients presented a preoperative Hb level of lower than 130 g per L. In addition, because iron sucrose is considered to be a safe IV iron formulation, 20 it is not surprising that no adverse effects of iron sucrose administration were witnessed either in this study or in the previous ones 9,10 . In addition, for patients with a preoperative Hb level of less than 130 g per L, our blood saving protocol seems to be as effective as either another more complex and expensive protocols, with rHuEPO alone 12,21 or in combination with other blood conservation methods, 22‐24 or a flow chart on the use of blood transfusion, with a lower transfusion trigger (Hb < 70 g/L) 25 …”